Low blood sugar levels hypoglycemia are a more serious risk linked to the glp 1 class of medications.
Glp 1 side effects.
Other common adverse effects include injection site reactions headache and nasopharyngitis but these effects do not usually result in discontinuation of the drug.
The most common symptoms associated with the use of glp 1 receptor agonists are gastrointestinal symptoms mainly nausea.
The drugs also commonly known as glucagon like peptide 1 glp 1 receptor agonists or glp 1 analogues are normally prescribed for patients who have not been able to control their condition with tablet medication.
Glp 1 ras commonly cause digestive side effects such as.
Change in taste loss of taste.
Side effects of incretin mimetics include.
These aes were generally dose dependent and mild in severity.
Bleeding blistering burning coldness discoloration of the skin feeling of pressure hives infection inflammation itching lumps numbness pain rash redness scarring soreness stinging swelling tenderness tingling ulceration or warmth at the injection site other side effects not listed may also occur in some patients.
Inflammation of the pancreas pancreatitis which may be severe is another side effect.
But the risk of low blood sugar levels is usually only increased if you re taking another medication known to lower blood sugar at the same time such as sulfonylureas or insulin.
Feelings of early fullness lower appetite nausea vomiting diarrhea.
Incretin mimetics are a relatively new group of injectable drugs for treatment of type 2 diabetes.
The most frequently reported treatment emergent adverse events aes were decreased appetite and gastrointestinal aes constipation diarrhea abdominal discomfort abdominal distension vomiting and nausea.